drugset / Trial / NCT02172963
A Pilot Study Using Placenta Derived Decidual Stromal Cells for Hemorrhagic Cystitis
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety and efficacy using placenta derived decidual stromal cell therapy for hemorrhagic cystitis after allogeneic hematopoietic cell transplantation. It is hypothesized that the decidual stromal cell therapy is safe to infuse and that they have a positive clinical effect.
Timeline
- Start
- 2011-11
- Primary completion
- 2013-12
- Completion
- 2013-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Decidual Stromal Cells | Cell therapy | 1e+06 cells/kg | Intravenous |
| Subject | Decidual Stromal Cells | Cell therapy | 2e+06 cells/kg | Intravenous |